Stock Price
225.11
Daily Change
-2.39 -1.05%
Monthly
-7.17%
Yearly
44.91%
Q2 Forecast
222.63

J&J reported $43M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
AbbVie USD 740M 40M Jun/2025
Abbott USD 68M 26M Mar/2026
Amgen USD 653M 32M Dec/2025
AstraZeneca USD 484M 181M Dec/2025
Baxter International USD 58M 14M Sep/2025
Bayer EUR 675M 87M Dec/2025
Becton, Dickinson and Co. USD 153M 2M Dec/2025
Biogen USD 72.6M 12.6M Jun/2025
Boston Scientific USD 90M 0 Mar/2026
Bristol-Myers Squibb USD 432M 48M Dec/2025
CONMED USD 7.37M 236K Dec/2025
Cooper Companies USD 22.4M 2M Dec/2025
Dexcom USD 4.7M 0 Sep/2025
Edwards Lifesciences USD 35.9M 2.7M Dec/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
Gilead Sciences USD 255M 1000K Dec/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
Globus Medical USD 17K 5.1B Dec/2025
Insulet USD 9.2M 2.2M Dec/2025
Integra LifeSciences USD 23.67M 953K Dec/2025
Intuitive Surgical USD 20.11B 58.39B Mar/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 181M 0 Dec/2025
Merck USD 412M 85M Dec/2025
Merit Medical Systems USD 6.36M 390K Dec/2025
Novartis USD 304M 23M Dec/2025
Pfizer USD 711M 59M Dec/2025
Regeneron Pharmaceuticals USD 12.2M 7.1M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 178M 203M Mar/2026
Stryker USD 157M 46.17B Sep/2025
Tandem Diabetes Care USD 2.07M 872.58M Dec/2025
Teva Pharmaceutical Industries USD 220M 17M Dec/2025
Vertex Pharmaceuticals USD 3.3M 0 Dec/2025
Zimmer Biomet Holdings USD 71.9M 3.5M Dec/2025
Zoetis USD 57M 1000K Dec/2025